Cargando…

Low prevalence of Blastocystis sp. in active ulcerative colitis patients

Ulcerative colitis (UC) is thought to originate from a disbalance in the interplay between the gut microbiota and the innate and adaptive immune system. Apart from the bacterial microbiota, there might be other organisms, such as parasites or viruses, that could play a role in the aetiology of UC. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossen, N. G., Bart, A., Verhaar, N., van Nood, E., Kootte, R., de Groot, P. F., D’Haens, G. R., Ponsioen, C. Y., van Gool, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409634/ https://www.ncbi.nlm.nih.gov/pubmed/25680316 http://dx.doi.org/10.1007/s10096-015-2312-2

Ejemplares similares

High prevalence of ulcerative appendicitis in patients with ulcerative colitis
por: Heuthorst, Lianne, et al.
Publicado: (2021)

Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands
por: Bart, Aldert, et al.
Publicado: (2013)

Ulcerative Colitis: Shifting Sands
por: D’Haens, Geert R. A. M., et al.
Publicado: (2019)

Blastocystis sp. Infection Mimicking Clostridium Difficile Colitis
por: Gil, Gaby S., et al.
Publicado: (2016)

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis
por: Berends, Sophie E., et al.
Publicado: (2018)

Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis
por: Haasnoot, Maria L, et al.
Publicado: (2022)

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis
por: Hanzel, Jurij, et al.
Publicado: (2021)

Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
por: Bots, Steven, et al.
Publicado: (2021)

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
por: Berends, Sophie E., et al.
Publicado: (2019)

Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
por: D’Haens, Geert, et al.
Publicado: (2023)

The safety of vedolizumab for ulcerative colitis and Crohn's disease
por: Colombel, Jean-Frédéric, et al.
Publicado: (2017)

Prevalence, predictors and clinical significance of Blastocystis sp. in Sebha, Libya
por: Abdulsalam, Awatif M, et al.
Publicado: (2013)

Prevalence and Subtype Distribution of Blastocystis sp. in Senegalese School Children
por: Khaled, Salma, et al.
Publicado: (2020)

Increased Proportion of Colorectal Cancer in Patients With Ulcerative Colitis Undergoing Surgery in the Netherlands
por: Heuthorst, Lianne, et al.
Publicado: (2023)

Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices
por: van Wassenaer, Elsa A, et al.
Publicado: (2022)

Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
por: Löwenberg, Mark, et al.
Publicado: (2023)

Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial
por: Rubin, David T., et al.
Publicado: (2016)

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
por: Sandborn, W. J., et al.
Publicado: (2015)

A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis
por: De Voogd, Floris, et al.
Publicado: (2021)

Epidemiological and Diagnostic Features of Blastocystis Infection in Symptomatic Patients in Izmir Province, Turkey
por: DAGCI, Hande, et al.
Publicado: (2014)

Prevalence and Subtype Distribution of Blastocystis sp. in Diarrheic Pigs in Southern China
por: Wang, Pei, et al.
Publicado: (2021)

The Prevalence of Blastocystis sp. and Its Relationship with Gastrointestinal Disorders and Risk factors
por: Viesy, Soghra, et al.
Publicado: (2022)

Prevalence and Association of Campylobacter spp., Salmonella spp., and Blastocystis sp. in Poultry
por: Guyard-Nicodème, Muriel, et al.
Publicado: (2023)

Randomised clinical study: discrepancies between patient‐reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis
por: Jharap, B., et al.
Publicado: (2015)

Exacerbation of colon carcinogenesis by Blastocystis sp.
por: Kumarasamy, Vinoth, et al.
Publicado: (2017)

Colorectal cancer and Blastocystis sp. infection
por: Sulżyc-Bielicka, Violetta, et al.
Publicado: (2021)

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
por: Yarlas, Aaron, et al.
Publicado: (2018)

Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
por: Willian, Mary Kaye, et al.
Publicado: (2018)

Prevalence and Molecular Characterisation of Blastocystis sp. Infecting Free-Ranging Primates in Colombia
por: Rondón, Silvia, et al.
Publicado: (2023)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients
por: Terveer, Elisabeth M, et al.
Publicado: (2019)

Exposure‐Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies
por: Mukherjee, Arnab, et al.
Publicado: (2022)

Long-term outcomes after close rectal dissection and total mesorectal excision in ileal pouch-anal anastomosis for ulcerative colitis
por: Reijntjes, M. A., et al.
Publicado: (2022)

Phenotypic variation in Blastocystis sp. ST3
por: Ragavan, Nanthiney Devi, et al.
Publicado: (2014)

Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52
por: Johnson, Travis, et al.
Publicado: (2023)

A prospective study comparing patient-reported outcomes in Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2020)

First Epidemiological Survey on the Prevalence and Subtypes Distribution of the Enteric Parasite Blastocystis sp. in Vietnam
por: Nguyen, Linh Do Ngoc, et al.
Publicado: (2023)

Blastocystis sp.: waterborne zoonotic organism, a possibility?
por: Lee, Li Ii, et al.
Publicado: (2012)

Update on the pathogenic potential and treatment options for Blastocystis sp
por: Roberts, Tamalee, et al.
Publicado: (2014)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ka3emoq87vb76va643u7orve8k